Biovica discuss the latest clinical results in Vatorpodden

Listen to Anders Rylander, CEO of Biovica and Mattias Bergqvist VP Sales & Marketing being interviewed in the latest edition of Vatorpodden. Anders and Mattias discuss the latest clinical results presented at the 2016 San Antonio Breast Cancer Symposium. The interview is available in Swedish (only)

January 2nd, 2017 15:00|News|

Biovica participates at SABCS, december 6-10, San Antonio

Biovica will attend the San Antonio Breast Cancer Symposium, an event that brings together oncology professionals from around the world. SABCS is the world’s leading breast cancer congress attracting more than 7,500 attendees from 90 countries. Read more at sabcs.org “At SABCS we will present new clinical study results in collaboration [...]

November 25th, 2016 13:30|News|

Meet Biovica at the World CDx Summit in Boston

Biovica will attend the 7th World Companion Diagnostic in Boston, October 18-21. The focus of the meeting is aligned with Biovicas strategy to rapidly progress exploratory biomarkers to registration, align clinical co-development and ensure reimbursement and market access success for precision therapies and assays. “At the World CDx meeting we look forward to meet partners [...]

September 28th, 2016 09:31|News|

Presentation of Biovica at unicorn summit capital market day

Anders Rylander, CEO and Mattias Bergqvist,VP Marketing & Clinical Development presented Biovica at an investors meeting at the IVA conference center in Stockholm. The meeting was arranged by Vator Securities. See below for the full presentation. (Swedish).

September 22nd, 2016 14:35|News|

Biovica attends capital market day

Biovica will give a company presentation at the annual Unicorn Summit Capital Market Day. The summit gathers some of the most interesting and innovative companies in Sweden and is arranged annually by Vator Securities AB. In addition to company presentations, the 150 attendees and participants have the opportunity to network with industry peers as well [...]

September 9th, 2016 09:00|News|

Kallelse till årsstämma i Biovica International AB

Styrelsen i Biovica International AB, org.nr 556774-6150, kallar härmed till årsstämma. Kallelsen i sin helhet kan läsas på länkad sida (länk) NOTICE OF ANNUAL GENERAL MEETING 2016 Biovica's shareholders are invited to the annual general meeting 2016. Shareholders meeting 2016 (link)

September 6th, 2016 11:17|News|

Biovica interviewed in Vatorpodden

Listen to Anders Rylander, CEO of Biovica and Mattias Bergqvist VP Sales & Marketing being interviewed in the latest edition of Vatorpodden. Anders and Mattias discuss challenges of cancer diagnostics and how Biovica assists with its products and technology. The interview is available in Swedish (only)

June 21st, 2016 13:36|News|

Biovica participates at ASCO, June 3-7, Chicago

Biovica will attend the ASCO Annual Meeting, an event that brings together 30 000 oncology professionals from around the world. Biovica aims to expand the collaboration and research network and to share the latest insights from on going clinical trials. “At ASCO we look forward to meet our academic partners and to expand [...]

May 31st, 2016 08:30|News|

Poster accepted for presentation at the 2016 aacr annual meeting in New Orleans

The American Association for Cancer Research (AACR) annual meeting is one of the largest gatherings of cancer researchers and oncologists in the world. The meeting is held 16-20 April in New Orleans. Biovica is attending the meeting to present a poster with new DiviTum™ results to demonstrate its use as a marker of efficacy for cell [...]

April 1st, 2016 09:00|News|

Biovica participates at the bio-europe conference, 4-6 april in Stockholm

Biovica will attend one of the largest partnering conferences serving the global biotechnology and pharmaceutical industry. The conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. This years spring meeting is arranged in Stockholm at Kistamässan. “With DiviTum™ we provide researchers and pharmaceutical companies with a tool for [...]

March 18th, 2016 09:00|News|